Meal replacement therapy for obesity and diabetes remission: efficacy assessment and considerations of barriers and facilitators to adherence among U.S. individuals with low economic resources
Claudia G. Durbin(Harvard University), Chika V. Anekwe(Harvard University), Jennifer Mulligan(Harvard University), Markella V. Zanni(Harvard University), Sreevidya Bodepudi(Harvard University), A. S. Hutchison, Talia Colecchi(University of Massachusetts Amherst)
Cited by 2
Related Papers
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
|JACC Heart Failure|2018|498
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Arterial Inflammation in Patients With HIV
|JAMA|2012|464
TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2010|320
Sex Differences in Circulating Biomarkers of Cardiovascular Disease
|Journal of the American College of Cardiology|2019|160